Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 ...

You step on the scale and see a few pounds gone; it feels like victory. But for many diabetics, that happiness doesn't last long. Fatigue, dizziness, and unstable blood sugar often follow. The truth ...

By Christy Santhosh March 19 (Reuters) - Eli Lilly's next-generation obesity drug showed a significant reduction in blood ...

Continuous glucose monitors are wearable devices that track your blood glucose levels 24 hours a day and provide real-time data on trends. CGMs use a sensor inserted into the skin and a transmitter to ...

A GIP/GLP-1/glucagon triple agonist reduced HbA1c by up to 1.9 percentage points at 40 weeks for adults with type 2 diabetes, ...

With the right steps, it’s possible to put type 2 diabetes into remission and restore healthy blood glucose levels. But how ...

New evidence shows that GLP-1–based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic ...

A major new study reveals that up to one in five people with prediabetes can return to normal blood sugar without losing weight, altering how doctors think about preventing type 2 diabetes. Study: ...

Artificial sugar for zero calories or regular sugar with calories? Dietitians weigh in.